Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Anne-Marie Pulichino.
Cell | 2001
Bruno Lamolet; Anne-Marie Pulichino; Thomas Lamonerie; Yves Gauthier; Thierry Brue; Alain Enjalbert; Jacques Drouin
The pituitary gland has provided unique insight into molecular mechanisms and regulatory factors controlling both differentiation and gene transcription. We identified Tpit, a novel T box factor only present in the two pituitary POMC-expressing lineages, the corticotrophs and melanotrophs, and apparently in no other tissue, including hypothalamic POMC neurons. In pituitary cells, Tpit activation of POMC gene transcription requires cooperation with Pitx1, the two factors binding to contiguous sites within the same regulatory element. In gain-of-function experiments, Tpit induces POMC expression in undifferentiated pituitary cells, indicating that it can initiate differentiation into POMC-expressing lineages. TPIT gene mutations were found in patients with isolated deficiency of pituitary POMC-derived ACTH, in support of an essential role of Tpit for differentiation of the pituitary POMC lineage.
Endocrine Research | 2004
Anne-Marie Pulichino; Bruno Lamolet; Sophie Vallette-Kasic; Gino Poulin; Khoi Chu; François Gillemot; Ming-Jer Tsai; Jacques Drouin
The hypothalamus-pituitary-adrenal (HPA) axis plays a primordial role in the control of homeostasis. Pituitary corticotroph cells produce POMC that is cleaved into ACTH. ACTH is an important regulator of HPA which stimulates production of glucocorticoids by the adrenals. The pituitary differentiation process is under the combined action of tissueand cell-restricted transcription factors. In corticotrophs, Tpit and NeuroD1 are both cell-specific activators of POMC expression. Their expression precedes closely that of POMC suggesting a role in differentiation of the lineage. We generated Tpit-/mice in which most Tpit coding sequences were replaced by a b-galactosidase gene. These mice are deficient in POMC-expressing cells consistent with a positive action of Tpit on these lineages; Tpit was also shown to be a negative regulator of the gonadotroph fate. However, the developing anterior pituitary of Tpit-/mice has a normal number of b-galactosidase and NeuroD1-positive cells, indicating that initiation of corticotroph differentiation is not prevented in the absence of Tpit. Corticotroph differentiation is delayed in NeuroD1-/mice but this is not resulting from
Current Opinion in Endocrinology & Diabetes | 2004
Anne-Marie Pulichino; Sophie Vallette-Kasic; Jacques Drouin
Purpose of reviewThe first model of simple relations among all pituitary lineages has been proposed in the past year. This has been possible through identification of transcription factors that control differentiation of pituitary lineages. This review will summarize current knowledge of the role of transcription factors in the control of pituitary cell differentiation and also in early organogenesis of the pituitary gland. Recent findingsThe T-box transcription factor Tpit has dual roles as positive regulator of the corticotroph and melanotroph lineages and as negative regulator of the gonadotroph lineage. This has suggested a common origin for these lineages and set them apart from the other lineages that were previously shown to be Pit1-dependent. These findings now allow all pituitary lineages to be integrated in a scheme of simple relations in which cell fate decisions are made through successive binary choices. Thus, various transcription factors control the processes of early pituitary patterning and organogenesis, of cell proliferation, and of cell differentiation. SummaryDiscovery of transcription factors responsible for pituitary cell differentiation and organogenesis has had an immediate impact on understanding and diagnosis of pituitary hormone deficiencies. Thus, combined pituitary hormone deficiencies have been associated with mutations in transcription factor coding genes that control organogenesis or multiple lineages, whereas isolated hormone deficiencies are often caused by transcription factors controlling late differentiation. The description of a simple model for pituitary cell differentiation also highlights regulatory mechanisms that remain to be identified to fully understand pituitary development and pituitary pathologies.
Endocrine Research | 2004
Sophie Vallette-Kasic; Anne-Marie Pulichino; Magali Gueydan; Anne Barlier; Michel David; Georges Malpuech; Cheri Deal; G. Van Vliet; M. de Vroede; Felix G. Riepe; Carl-Joachim Partsch; Wolfgang G. Sippell; Merih Berberoglu; Begüm Atasay; F. de Zegher; Jennifer Kyllo; Patricia A. Donohoue; P. Dechelotte; Martin Fassnacht; K. Noordam; Leo Dunkel; B. Pigeon; Jacques Weill; Sevket Yigit; Raja Brauner; Juliane Léger; J.J. Heinrich; Alain Enjalbert; Thierry Brue; Jacques Drouin
Tpit is a T-box transcription factor involved in terminal differentiation of the pituitary POMC-expressing cells. We previously demonstrated that human and mice mutations of the highly cortico/melanotroph specific transcription factor gene Tpit cause a neonatal onset form of congenital isolated ACTH deficiency (IAD). In the absence of glucocorticoid replacement, IAD can lead to neonatal death by acute adrenal insufficiency. This clinical entity was not previously well characterized because of the small number of published cases. We investigated the Tpit gene coding sequences in 28 patients (22 unrelated families) presenting with neonatal onset IAD. We found a Tpit mutation in 17/28 patients (61%). We identified 10 different Tpit mutations with a high frequency site in exon 6, which was found in 5 unrelated families. All patients were homozygous or compound heterozygotes for Tpit mutations, and their unaffected parents were all heterozygous carriers, confirming the recessive mode of transmission. It is noteworthy that five compound heterozygotes involving different mutations were identified. We compared the clinical and biological phenotype of the 17 IAD patients carrying a Tpit mutation with the 11 remaining IAD patients and we didn’t find any
Genes & Development | 2003
Anne-Marie Pulichino; Sophie Vallette-Kasic; Catherine Couture; Yves Gauthier; Thierry Brue; Michel David; Georges Malpuech; Cheri Deal; Guy Van Vliet; Monique De Vroede; Felix G. Riepe; Carl-Joachim Partsch; Wolfgang G. Sippell; Merih Berberoglu; Begüm Atasay; Jacques Drouin
Genes & Development | 2003
Anne-Marie Pulichino; Sophie Vallette-Kasic; Judy Peih-Ying Tsai; Catherine Couture; Yves Gauthier; Jacques Drouin
The Journal of Clinical Endocrinology and Metabolism | 2005
Sophie Vallette-Kasic; Thierry Brue; Anne-Marie Pulichino; Magali Gueydan; Anne Barlier; Michel David; Marc Nicolino; Georges Malpuech; Pierre Déchelotte; Cheri Deal; Guy Van Vliet; Monique De Vroede; Felix G. Riepe; Carl-Joachim Partsch; Wolfgang G. Sippell; Merih Berberoglu; Begüm Atasay; Francis de Zegher; Dominique Beckers; Jennifer Kyllo; Patricia A. Donohoue; Martin Fassnacht; Stefanie Hahner; Bruno Allolio; C. Noordam; Leo Dunkel; Matti Hero; B. Pigeon; Jacques Weill; Sevket Yigit
Journal of Biological Chemistry | 2003
Mario Maira; Catherine Couture; Gwendal Le Martelot; Anne-Marie Pulichino; Steve Bilodeau; Jacques Drouin
The Journal of Clinical Endocrinology and Metabolism | 2003
Sophie Vallette-Kasic; Dominique Figarella-Branger; Michel Grino; Anne-Marie Pulichino; Henry Dufour; F. Grisoli; Alain Enjalbert; Jacques Drouin; Thierry Brue
M S-medecine Sciences | 2004
Anne-Marie Pulichino; Sophie Vallette-Kasic; Catherine Couture; Thierry Brue; Jacques Drouin